Healing peptides and tissue repair
When you strain a tendon or overwork a muscle, your body runs a repair sequence: inflammation, new blood vessels, rebuilt tissue. So-called healing peptides like BPC-157 and TB-500 are studied for how they interact with that sequence.
Most of the research so far is preclinical — worth understanding before forming expectations — and these articles are honest about that line. They cover the mechanisms, the evidence, and the practical questions people ask, with every compound available only by prescription after a provider review.
43 articles on this topic
-

KPV Peptide and the Gut Inflammation Evidence
KPV is the C-terminal tripeptide of alpha-MSH, and in mice whose MC1R does not function, every animal in the KPV-treated group survived DSS colitis — a result that points away from melanocortin receptors entirely.
-

TB-500 for Injury Recovery, Tissue by Tissue
TB-500 is a synthetic fragment of thymosin beta-4. Human studies of the full-length parent also include intravenous Phase 1 safety and pharmacokinetic trials and topical ophthalmic trials, in addition to Phase 2 chronic-wound studies.
-

Wolverine Peptide Stack: Two Peptides, One Rx
BPC-157 and TB-500 are usually sold together as the Wolverine peptide stack. This is what the published research measured, what it did not, and how a prescription evaluation works.
Page 3 of 3 · 43 articles